top of page
Neosoma Brain Mets
FDA Cleared and fully-integrated with Neosoma's proprietary cloud platform, with novel mets-specific interfaces, reports, and capabilities, Neosoma Brain Mets is a new paradigm in the efficient assessment and auto-contouring of metastatic brain lesions for the entire multidisciplinary team.

* Footnotes:​
-
Study processing times based on internal Neosoma benchmarks.
-
Algorithm performance data from retrospective FDA performance testing, to be published.
bottom of page





